MarketCap
Facebook
X
TelegramQuarterly report 2025-Q1
added 04-22-2025
Danaher Corporation Book Value 2011-2025 | DHR
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Danaher Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77.5 B | 84.5 B | 84.4 B | 83.2 B | 76.2 B | 30.3 B | 28.2 B | 26.4 B | 23.1 B | 23.8 B | 23.4 B | 22.5 B | 19.1 B | 17 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 84.5 B | 17 B | 44.2 B |
Quarterly Book Value Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 81.8 B | 83.4 B | 83.2 B | 82.5 B | 78 B | 83.2 B | 76.2 B | 76.2 B | 76.2 B | 76.2 B | 62.1 B | 62.1 B | 62.1 B | 62.1 B | 47.8 B | 47.8 B | 47.8 B | 47.8 B | 46.6 B | 46.6 B | 46.6 B | 46.6 B | 45.3 B | 45.3 B | 45.3 B | 45.3 B | 48.2 B | 48.2 B | 48.2 B | 48.2 B | 37 B | 37 B | 37 B | 37 B | 34.7 B | 34.7 B | 34.7 B | 34.7 B | 32.9 B | 32.9 B | 32.9 B | 32.9 B | 29.9 B | 29.9 B | 29.9 B | 29.9 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 83.4 B | 29.9 B | 50.8 B |
Book Value of other stocks in the Diagnostics research industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
77.2 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
141 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
-22.3 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
75.7 M | $ 19.06 | -1.6 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
1.85 B | $ 20.31 | -5.8 % | $ 221 M |  China |
 |
Co-Diagnostics
CODX
|
86 M | $ 0.23 | -4.17 % | $ 6.75 M | USA |
 |
Biocept
BIOC
|
8.86 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
17.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
456 M | $ 39.2 | -0.49 % | $ 1.09 B | USA |
 |
DarioHealth Corp.
DRIO
|
96.4 M | $ 10.36 | 3.19 % | $ 294 M | Israel |
 |
BioNano Genomics
BNGO
|
35.4 M | $ 1.51 | -0.9 % | $ 1.92 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
16.7 M | - | - | $ 562 M |  Britain |
 |
Exact Sciences Corporation
EXAS
|
2.4 B | $ 101.86 | 0.28 % | $ 18.9 B | USA |
 |
DexCom
DXCM
|
2.07 B | $ 67.65 | 0.12 % | $ 26.1 B | USA |
 |
Enzo Biochem
ENZ
|
56.1 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
1.13 B | $ 26.63 | -0.34 % | $ 805 M | USA |
 |
Global Cord Blood Corporation
CO
|
4.88 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
132 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
16.4 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
548 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
57.2 M | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.32 B | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
261 M | $ 19.19 | -1.49 % | $ 1.03 B | USA |
 |
Celcuity
CELC
|
116 M | $ 101.0 | -1.22 % | $ 3.98 B | USA |
 |
Heska Corporation
HSKA
|
422 M | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
18.9 M | $ 3.19 | -0.31 % | $ 102 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
5.39 M | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
6.07 B | $ 227.26 | 0.15 % | $ 41.2 B | USA |
 |
Guardant Health
GH
|
-140 M | $ 100.93 | -1.99 % | $ 12.4 B | USA |
 |
Aspira Women's Health
AWH
|
6.73 M | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
701 M | $ 6.32 | -2.55 % | $ 573 M | USA |
 |
ENDRA Life Sciences
NDRA
|
2.56 M | $ 4.75 | -4.81 % | $ 2.55 M | USA |
 |
Neogen Corporation
NEOG
|
2.07 B | $ 7.2 | 0.98 % | $ 1.56 B | USA |
 |
National Research Corporation
NRC
|
49 M | $ 18.95 | 1.55 % | $ 465 M | USA |
 |
Illumina
ILMN
|
6.3 B | $ 134.56 | -0.29 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
3.51 B | $ 203.33 | -0.11 % | $ 10.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
16.2 B | $ 175.36 | -0.34 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
20.9 M | $ 6.79 | -0.44 % | $ 880 M | USA |
 |
Motus GI Holdings
MOTS
|
2.69 M | - | -34.28 % | $ 263 K | Israel |
 |
Koninklijke Philips N.V.
PHG
|
12 B | $ 27.26 | 0.57 % | $ 20 B |  Niderland |
 |
Laboratory Corporation of America Holdings
LH
|
8.07 B | $ 252.95 | -0.4 % | $ 21.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
9.52 B | $ 182.75 | -0.05 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.6 B | $ 685.99 | -0.36 % | $ 56.6 B | USA |
 |
Lantheus Holdings
LNTH
|
1.09 B | $ 67.0 | 0.43 % | $ 4.64 B | USA |
 |
Personalis
PSNL
|
203 M | $ 8.01 | -1.6 % | $ 475 M | USA |
 |
Mettler-Toledo International
MTD
|
-127 M | $ 1 419.41 | -0.06 % | $ 30.1 B |  Schweiz |
 |
Agilent Technologies
A
|
5.39 B | $ 138.09 | -0.22 % | $ 42 B | USA |
 |
Quidel Corporation
QDEL
|
11.9 B | $ 29.27 | -0.12 % | $ 1.23 B | USA |
 |
Biomerica
BMRA
|
4.1 M | $ 2.6 | -3.7 % | $ 5.97 M | USA |